Live Feeds
● LIVE Updated 2d ago · 13 sources tracked

Blood pressure medication recalled nationwide over manufacturing issue

The FDA issued a nationwide recall for more than 11,000 bottles of the blood pressure drug chlorthalidone. The recall stems from manufacturing issues, specifically failed dissolution specifications. Affected products include 100-count and 1,000-count bottles.

RSS Source map (13)

What changed

New details identify the specific drug as chlorthalidone and the distributor as Rising Pharma Holdings Inc.

Live updates

  1. FDA Recalls Over 11,000 Bottles of Chlorthalidone Blood Pressure Medication

    The FDA issued a nationwide recall for more than 11,000 bottles of the blood pressure drug chlorthalidone. The recall stems from manufacturing issues, specifically failed dissolution specifications. Affected products include 100-count and 1,000-count bottles.

    What's confirmed:

    • The FDA issued a nationwide recall for more than 11,000 bottles of chlorthalidone blood pressure medication.
    • The recall is due to failed dissolution specifications.
    • The recall involves 100-count and 1,000-count bottles distributed in the United States by Rising Pharma Holdings Inc. of New Jersey.
    • The medication is being recalled because of a manufacturing issue.
    confidence 100%